skip to Main Content
News & Publications
Biolocity/DRIVe/BARDA funding, 2021:

The Biolocity program has selected five promising and patient-focused technologies for its new cohort of Biolocity Launch, a year-long collaboration that helps faculty members commercialize their innovations. We are pleased to announced that our project was selected! Learn more at We are so grateful for Biolocity’s support. Since 2015, the program has awarded more than $8.7 million across 58 projects, generating over 10 times that much follow-on investment. Learn more about Biolocity at 

Georgia Research Alliance funding, Phase, 2021:

The Georgia Research Alliance grows Georgia’s economy by expanding university research capacity and seeding and shaping startup companies around inventions and discoveries. The GRA is supporting the development of Pediatric πCIT™ in collaboration with the Children’s Healthcare of Atlanta! Learn more at

CREATE-X Startup Program 2021:

SANICKA was awarded the CREATE-X Faculty Grant. The 12 weeks program includes funding, legal services, full-time coaching from startup experts, mentoring from industry professionals, 24/7 access to collaborative space, and networking with other startups. Learn more at

I-Corps Teams, 2019:

Dr. Ana Quiroga and Esther Chen along with our business mentor, Nakia Melecio, traveled all around the US and Switzerland to visit biotech hubs as a part of the national NSF I-Corps Teams. The aim of this intense program is to get academic researchers out of their comfort zone and into the field to evaluate the commercial potential of their technology. The 7-weeks programs provide a methodology supported by advice, resources, networking opportunities, coaching and funding to enable nascent commercialization teams to do early customer evaluation.

Personalized Model-based Optimization

Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia (AML)

Computers & Chemical Engineering

Personalized Model-based Optimization

A personalized framework for dynamic modeling of disease trajectories in chronic lymphocytic leukemia.

IEEE Transactions on Biomedical Engineering

Population Balance Models

A mathematical model of subpopulation kinetics for the deconvolution of leukaemia heterogeneity.

Journal of the Royal Society Interface

Population Balance Models

Cyclin and DNA distributed cell cycle model for GS-NS0 cells.

PLoS computational biology

PK / PD Models

Chemotherapy drug scheduling for the induction treatment of patients with acute myeloid leukemia.

IEEE Transactions on Biomedical Engineering

AML & Immune Response

Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukemia (AML).

Leukemia 2003

AML & Immune Response

Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.

Cancer Immunol, Immunotherapy 2021

Back To Top